ArticleCell cycle (Georgetown, Tex.)2015
Corrigendum.
Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Article title: The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid. Authors: Birgit Steinmetz, Hubert Hackl, Eva Slabakova, Ilse Schwarzinger, Monika Smejova, Andreas Spittler, Itziar Arbesu, Medhat Shehata, Karel Soucek, and Rotraud Wieser. Journal: Cell Cycle. Bibliometrics: Volume 13, Issue 18, Pages 2931–43. DOI: 10.4161/15384101.2014.946869. The following information was missing from the Methods section in print and online: Microarray data described in this article were deposited in the gene expression omnibus, accession numbers GSE66837 and GSE66854. The authors apologize for any inconvenience caused.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.